Prospective comparison of prostatic aspirate culture and cystocentesis urine culture for detection of bacterial infection in dogs with prostatic neoplasia.

J Small Anim Pract

Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, California, USA.

Published: December 2022

Objective: The purpose of this study was to determine whether prostatic aspirate culture is a superior method to detect infection compared to culture of urine collected by cystocentesis in dogs with prostatic neoplasia.

Materials And Methods: A prospective study was conducted and dogs with suspected or confirmed prostatic neoplasia were enrolled. Urinalysis was done and culture and antimicrobial susceptibility testing was performed on paired urine and prostatic aspirate samples collected at a single timepoint.

Results: Ten dogs with prostatic neoplasia were enrolled. All dogs had one or more clinical sign consistent with lower urinary tract disease. One dog (10%) had a positive urine culture, but negative prostatic aspirate culture, one dog (10%) had a positive prostatic aspirate culture, but negative urine culture, and one dog (10%) had both positive urine and prostatic aspirate cultures. Using prostatic aspirate culture as the reference standard, urine culture had a sensitivity for detecting infection of 87.5% (95% confidence interval 52.9 to 99.4) and specificity of 50% (92.6 to 97.4) in this population of dogs.

Clinical Significance: Positive cultures were uncommon with both culture collection methods. Study results did not identify prostatic aspirate culture to be a more sensitive method of detecting prostatic infection than urine culture collected by cystocentesis in these dogs with prostatic neoplasia.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jsap.13556DOI Listing

Publication Analysis

Top Keywords

prostatic aspirate
32
aspirate culture
24
urine culture
20
dogs prostatic
16
prostatic neoplasia
16
prostatic
14
culture
14
dog 10%
12
10% positive
12
aspirate
8

Similar Publications

We report here a rare case of a concurrent occurrence of abscesses caused by  in the prostate, seminal vesicles, and epididymis. A 71-year-old male presented to our hospital with urinary retention, and an indwelling urethral catheter was inserted. He remained afebrile until a revisit one month later when he developed a fever and left scrotal swelling.

View Article and Find Full Text PDF

An MDS Patient with Deletion 20q and a t(9;22)(q34;q11.2): A Case Report and Review of the Literature.

J Assoc Genet Technol

January 2024

The International Circle of Genetics Studies, Stony Brook Chapter, NY.

We report a 76-year-old male patient with myelodysplastic syndrome (MDS) with a t(9;22) and deletion 20q only by FISH. Past medical history is significant for prostate cancer status post radiation therapy and a 28-pack-year smoking history. In 2016, the patient developed a DVT and incidentally was found to have a BCR::ABL1 (p210) by PCR analysis (level of 0.

View Article and Find Full Text PDF

Polyploid cancer cells reveal signatures of chemotherapy resistance.

Oncogene

November 2024

Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA, USA.

Article Synopsis
  • Therapeutic resistance in cancer, especially in advanced prostate cancer, contributes to high mortality as patients often relapse after initial treatments.
  • Research on circulating tumor cells with increased genomic content (CTC-IGC) from 44 advanced prostate cancer patients reveals a link to poorer survival outcomes and clonal origins, indicating polyploidization.
  • Identification of new RNA and protein markers associated with chemotherapy resistance, such as HOMER1, TNFRSF9, and LRP1, suggests pathways for improving cancer treatment and understanding relapse mechanisms.
View Article and Find Full Text PDF

Background: Cabazitaxel is an effective treatment in metastatic castration-resistant prostate cancer (mCRPC) patients previously exposed to docetaxel and novel hormonal treatments. Understanding the molecular biology of mCRPC disease and taking into account the several approved treatment options, biomarkers are needed to guide decision making including cabazitaxel treatment.

Methods: Cababone was a phase II translational study that attempted to identify predictors of cabazitaxel efficacy.

View Article and Find Full Text PDF

The Value of Renal Clinical Nurse Specialists: Future Potential and Current Challenges in the United Kingdom.

Semin Oncol Nurs

December 2024

Lead Clinical Nurse Specialist Gestational Trophoblastic Disease and Rare Gynae Cancers, Imperial College.

Article Synopsis
  • The renal clinical nurse specialist (CNS) serves as a vital support and information source for patients with kidney cancer, especially during advanced treatment stages.
  • There are challenges in the UK, including a decreasing urology workforce and a recruitment crisis that leaves many new CNSs without necessary competencies.
  • Improved kidney cancer treatments require dedicated CNSs to help manage patient care throughout the cancer journey, supported by educational initiatives like ACCEND and RCC4Nurses to enhance CNS skills and effectiveness.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!